Alvogen - Fentanyl transdermal system 25 mcg/h 

Alvogen announced a voluntary, consumer level recall of one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches because there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch.

 

Classification Type: Class 1 Recall

Optum Clinical Services has sent a drug recall notification to potentially impacted members and providers.

 

Below are the notification details.